Tens of millions of people around the world are now taking drugs like Ozempic — a kind of real-time experiment that offers far more data than a carefully controlled clinical trial can.
…
Here’s what we’ve learned in the process.
They can treat much more than just diabetes or obesity.
… [S]ome of them have now been approved to reduce the risk of heart attacks and other cardiovascular issues and to treat sleep apnea, severe liver disease and kidney disease.
…
You regain weight if you stop taking them — but not necessarily all of it.
…
They don’t work equally well for everyone.
We now know that about one in 10 people on the drugs are what scientists call “non-responders” who lose less than 5 percent of their body weight.
Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.
They can have unexpected downsides. …
…
Related on the SLP
The “right dose” is up for debate.
…
They affect more than just your body.
… The idea that the drugs might diminish pleasure, or even joy, in some patients has shown up ….
